Gonda 8-104/Joseph 1-242

Behavioral Neurology
David Knopman, M.D.
"The Alzheimer Disease Spectrum from the Perspective of Imaging Biomarkers"

Learning objective:
Describe how Imaging Biomarkers are being used to redefine the pathophysiology of Alzheimer's disease

The presenter has the following relevant financial relationships to disclose:
Consultant - DSMB member of DIAN-TU (AD prevention); and Lundbeck anti-AD drug
Grant/Research Support - Lilly, Biogen, TauRX
The presenter does not intend to discuss an off-label/investigative use of a commercial product/device.